A shot in the arm
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
A new control switch could make RNA therapies easier to program
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
A traveler on bioengineering’s many paths
Immunology research, public health service, and student leadership are all part of senior Julian Zulueta’s journey toward becoming a physician-scientist.
Why lung cancer doesn’t respond well to immunotherapy
A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.
Targeting cancer with a multidrug nanoparticle
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
MIT researchers develop an AI model that can detect future lung cancer risk
Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.
Compassion in the details
The late MIT Professor Angelika Amon was recognized as Committed to Caring for her generous and encompassing mentorship.
Enzyme “atlas” helps researchers decipher cellular pathways
Biologists have mapped out more than 300 protein kinases and their targets, which they hope could yield new leads for cancer drugs.
New tool can assist with identifying carbohydrate-binding proteins
Groundbreaking research can help alleviate the challenges affiliated with studying carbohydrates.
Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research
Koch Institute event celebrates the new MIT Press biography “Salvador Luria: An Immigrant Biologist in Cold War America.”
Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
A new control system for synthetic genes
Researchers have developed a technique that could help fine-tune the production of monoclonal antibodies and other useful proteins.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
Two first-year students named Rise Global Winners for 2022
Now in its second year, the Rise program targets exceptional teenage scholars from around the world for their potential as future change-makers.
A “door” into the mitochondrial membrane
Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.